Microextraction by packed Sorbent (MEPS) and solid-phase microextraction (SPME) as sample preparation procedures for the metabolomic profiling of urine

Metabolites

Volumn 4, Issue 1, 2014, Pages 71-97

  Silva, Catarina ^a   Cavaco, Carina ^a   Perestrelo, Rosa ^a   Pereira, Jorge ^a   Câmara, José S ^a  

^a UNIVERSITY OF MADEIRA   (Portugal)

Author keywords

Metabolomics; Microextraction by packed sorbent; Solid phase microextraction; Urine

Indexed keywords

BIOLOGICAL MARKER; SORBENT;

CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; EARLY DIAGNOSIS; ELUTION; EXTRACTION AND EXTRACTS; FIBER; GAS CHROMATOGRAPHY; HUMAN; IONIC STRENGTH; LIQUID CHROMATOGRAPHY; METABOLOMICS; MICROEXTRACTION BY PACKED SORBENT; MOLECULAR WEIGHT; NONHUMAN; ONCOLOGY; PARTITION COEFFICIENT; REVIEW; SAMPLING; SENSITIVITY AND SPECIFICITY; SOLID PHASE MICROEXTRACTION; TEMPERATURE; URINALYSIS;

EID: 84922769583     PISSN: None     EISSN: 22181989     Source Type: Journal    
DOI: 10.3390/metabo4010071     Document Type: Review

References (133)

1. Kataoka, H. Automated sample preparation using in-tube solid-phase microextraction and its application-a review. Anal. Bioanal. Chem. 2002, 373, 31-45.
2. Kataoka, H.; Ishizaki, A.; Nonaka, Y.; Saito, K. Developments and applications of capillary microextraction techniques: A review. Anal. Chim. Acta 2009, 655, 8-29.
3. Kataoka, H. New trends in sample preparation for clinical and pharmaceutical analysis. Trends Anal. Chem. 2003, 22, 232-244.
4. Mitra, S. Sample Preparation Techniques in Analytical Chemistry; John Wiley & Sons Inc.: Hoboken, NJ, USA, 2004; Volume 237.
5. Mendes, B.; Gonçalves, J.; Câmara, J.S. Effectiveness of high-throughput miniaturized sorbent-and solid phase microextraction techniques combined with gas chromatography-mass spectrometry analysis for a rapid screening of volatile and semi-volatile composition of wines-a comparative study. Talanta 2012, 88, 79-94.
6. Perestrelo, R.; Nogueira, J.; Câmara, J. Potentialities of two solventless extraction approaches-stir bar sorptive extraction and headspace solid-phase microextraction for determination of higher alcohol acetates, isoamyl esters and ethyl esters in wines. Talanta 2009, 80, 622-630.
7. Silva, C.L.; Gonçalves, J.L.; Câmara, J.S. A sensitive microextraction by packed sorbent-based methodology combined with ultra-high pressure liquid chromatography as a powerful technique for analysis of biologically active flavonols in wines. Anal. Chim. Acta 2012, 739, 89-98.
8. Jeleń, H.H.; Majcher, M.; Dziadas, M. Microextraction techniques in the analysis of food flavor compounds: A review. Anal. Chim. Acta 2012, 738, 13-26.
9. Pereira, J.; Gonçalves, J.; Alves, V.; Câmara, J. Microextraction using packed sorbent as an effective and high-throughput sample extraction technique: Recent applications and future trends. Sample Prep. 2013, 1, 38-53.
10. Kataoka, H.; Saito, K. Recent advances in spme techniques in biomedical analysis. J. Pharm. Biomed. Anal. 2011, 54, 926-950.
11. Abdel-Rehim, M. Recent advances in microextraction by packed sorbent for bioanalysis. J. Chromatogr. A 2010, 1217, 2569-2580.
12. Nováková, L.; Vlčková, H. A review of current trends and advances in modern bio-analytical methods: Chromatography and sample preparation. Anal. Chim. Acta 2009, 656, 8-35.
13. Pereira, J.; Silva, C.L.; Perestrelo, R.; Gonçalves, J.; Alves, V.; Câmara, J.S. Re-exploring the high-throughput potential of microextraction techniques, spme and meps, as powerful strategies for medical diagnostic purposes. Innovative approaches, recent applications and future trends. Anal. Bioanal. Chem. 2014, doi:10.1007/s00216-013-7527-4.
14. Alves, G.; Rodrigues, M.; Fortuna, A.; Falcão, A.; Queiroz, J. A critical review of microextraction by packed sorbent as a sample preparation approach in drug bioanalysis. Bioanalysis 2013, 5, 1409-1442.
15. Arthur, C.L.; Pawliszyn, J. Solid phase microextraction with thermal desorption using fused silica optical fibers. Anal. Chem. 1990, 62, 2145-2148.
16. Zambonin, C.G.; Quinto, M.; de Vietro, N.; Palmisano, F. Solid-phase microextraction-gas chromatography mass spectrometry: A fast and simple screening method for the assessment of organophosphorus pesticides residues in wine and fruit juices. Food Chem. 2004, 86, 269-274.
17. Perestrelo, R.; Petronilho, S.; Câmara, J.S.; Rocha, S.M. Comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry combined with solid phase microextraction as a powerful tool for quantification of ethyl carbamate in fortified wines. The case study of madeira wine. J. Chromatogr. A 2010, 1217, 3441-3445.
18. Ferreira, L.; Perestrelo, R.; Caldeira, M.; Câmara, J.S. Characterization of volatile substances in apples from rosaceae family by headspace solid-phase microextraction followed by GC-qMS. J. Sep. Sci. 2009, 32, 1875-1888.
19. Oliveira e Silva, H.; de Pinho, P.G.; Machado, B.P.; Hogg, T.; Marques, J.; Câmara, J.S.; Albuquerque, F.; Silva Ferreira, A.C. Impact of forced-aging process on madeira wine flavor. J. Agric. Food Chem. 2008, 56, 11989-11996.
20. Perestrelo, R.; Caldeira, M.; Rodrigues, F.; Camara, J.S. Volatile flavour constituent patterns of terras madeirenses red wines extracted by dynamic headspace solid-phase microextraction. J. Sep. Sci. 2008, 31, 1841-1850.
21. Câmara, J.; Marques, J.; Alves, A.; Ferreira, A.S. Heterocyclic acetals in madeira wines. Anal. Bioanal. Chem. 2003, 375, 1221-1224.
22. Ouyang, G.; Pawliszyn, J. A critical review in calibration methods for solid-phase microextraction. Anal. Chim. Acta 2008, 627, 184-197.
23. Dietz, C.; Sanz, J.; Cámara, C. Recent developments in solid-phase microextraction coatings and related techniques. J. Chromatogr. A 2006, 1103, 183-192.
24. Turiel, E.; Martín-Esteban, A. Molecularly imprinted polymers for solid-phase microextraction. J. Sep. Sci. 2009, 32, 3278-3284.
25. Spietelun, A.; Pilarczyk, M.; Kloskowski, A.; Namieśnik, J. Current trends in solid-phase microextraction (SPME) fibre coatings. Chem. Soc. Rev. 2010, 39, 4524-4537.
26. Pawliszyn, J.; Pedersen-Bjergaard, S. Analytical microextraction: Current status and future trends. J. Chromatogr. Sci. 2006, 44, 291-307.
27. Spietelun, A.; Kloskowski, A.; Chrzanowski, W.; Namieśnik, J. Understanding solid-phase microextraction: Key factors influencing the extraction process and trends in improving the technique. Chem. Rev. 2012, 113, 1667-1685.
28. Pawliszyn, J. Theory of solid-phase microextraction. J. Chromatogr. Sci. 2000, 38, 270-278.
29. Vas, G.; Vekey, K. Solid-phase microextraction: A powerful sample preparation tool prior to mass spectrometric analysis. J. Mass Spectrom. 2004, 39, 233-254.
30. Vuckovic, D.; Zhang, X.; Cudjoe, E.; Pawliszyn, J. Solid-phase microextraction in bioanalysis: New devices and directions. J. Chromatogr. A 2010, 1217, 4041-4060.
31. Kataoka, H.; Lord, H.L.; Pawliszyn, J. Applications of solid-phase microextraction in food analysis. J. Chromatogr. A 2000, 880, 35-62.
32. Perestrelo, R.; Barros, A.S.; Rocha, S.M.; Câmara, J.S. Optimisation of solid-phase microextraction combined with gas chromatography-mass spectrometry based methodology to establish the global volatile signature in pulp and skin of vitis vinifera l. Grape varieties. Talanta 2011, 85, 1483-1493.
33. Gonçalves, J.; Câmara, J.S. New method for determination of (E)-resveratrol in wine based on microextraction using packed sorbent and ultra-performance liquid chromatography. J. Sep. Sci. 2011, 34, 2376-2384.
34. Abdel-Rehim, A.; Abdel-Rehim, M. Screening and determination of drugs in human saliva utilizing microextraction by packed sorbent and liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 2013, 27, 1188-1191.
35. Abdel-Rehim, M. Microextraction by packed sorbent (MEPS): A tutorial. Anal. Chim. Acta 2011, 701, 119-128.
36. Abdel-Rehim, M. New trend in sample preparation: On-line microextraction in packed syringe for liquid and gas chromatography applications: I. Determination of local anaesthetics in human plasma samples using gas chromatography-mass spectrometry. J. Chromatogr. B 2004, 801, 317-321.
37. Zhang, A.; Sun, H.; Wang, P.; Han, Y.; Wang, X. Recent and potential developments of biofluid analyses in metabolomics. J. Proteomics 2012, 75, 1079-1088.
38. Zhang, A.; Sun, H.; Wu, X.; Wang, X.; Urine metabolomics. Clin. Chim. Acta 2012, 414, 65-69.
39. Ryan, D.; Robards, K.; Prenzler, P.D.; Kendall, M. Recent and potential developments in the analysis of urine: A review. Anal. Chim. Acta 2011, 684, 17-29.
40. Dong, H.; Zhang, A.; Sun, H.; Wang, H.; Lu, X.; Wang, M.; Ni, B.; Wang, X. Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of chuanwu in wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods. Mol. Biosyst. 2012, 8, 1206-1221.
41. Silva, C.L.; Passos, M.; Câmara, J.S. Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers-a powerful strategy for breast cancer diagnosis. Talanta 2012, 89, 360-368.
42. Kemperman, R.F.; Horvatovich, P.L.; Hoekman, B.; Reijmers, T.H.; Muskiet, F.A.; Bischoff, R. Comparative urine analysis by liquid chromatography-mass spectrometry and multivariate statistics: Method development, evaluation, and application to proteinuria. J. Proteome Res. 2007, 6, 194-206.
43. Denkert, C.; Bucher, E.; Hilvo, M.; Salek, R.; Orešič, M.; Griffin, J.; Brockmöller, S.; Klauschen, F.; Loibl, S.; Barupal, D.K.; et al. Metabolomics of human breast cancer: New approaches for tumor typing and biomarker discovery. Genome Med. 2012, 4, 37-37.
44. Zhang, Y.; Wang, G.-J.; Song, T.T.; Murphy, P.A.; Hendrich, S. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity. J. Nutr. 1999, 129, 957-962.
45. Wang, X.; Zhang, A.; Han, Y.; Wang, P.; Sun, H.; Song, G.; Dong, T.; Yuan, Y.; Yuan, X.; Zhang, M.; et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol. Cell. Proteomics 2012, 11, 370-380.
46. Temmerman, L.; de Livera, A.; Bowne, J.; Sheedy, J.; Callahan, D.; Nahid, A.; de Souza, D.; Schoofs, L.; Tull, D.; McConville, M.; et al. Cross-platform urine metabolomics of experimental hyperglycemia in type 2 diabetes. J. Diabetes Metab. 2012, 6, doi:10.4172/2155-6156.S6-02.
47. Carrola, J.; Rocha, C.U.M.; Barros, A.N.S.; Gil, A.M.; Goodfellow, B.J.; Carreira, I.M.; Bernardo, J.O.; Gomes, A.; Sousa, V.; Carvalho, L.; et al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J. Proteome Res. 2010, 10, 221-230.
48. Slupsky, C.M.; Steed, H.; Wells, T.H.; Dabbs, K.; Schepansky, A.; Capstick, V.; Faught, W.; Sawyer, M.B. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin. Cancer Res. 2010, 16, 5835-5841.
49. Serkova, N.J.; Glunde, K. Metabolomics of Cancer. In Tumor Biomarker Discovery; Springer: Berlin, Germany, 2009; pp. 273-295.
50. Cho, S.H.; Jung, B.H.; Lee, S.H.; Lee, W.Y.; Kong, G.; Chung, B.C. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 2006, 20, 1229-1236.
51. Loft, S.; Olsen, A.; Moller, P.; Poulsen, H.E.; Tjonneland, A. Association between 8-oxo-7, 8-dihydro-2′-deoxyguanosine excretion and risk of postmenopausal breast cancer: Nested case-control study. Cancer Epidemiol. Biomark. Prev. 2013, 22, 1289-1296.
52. Nam, H.; Chung, B.C.; Kim, Y.; Lee, K.; Lee, D. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics 2009, 25, 3151-3157.
53. Kim, D.S.; Choi, Y.D.; Moon, M.; Kang, S.; Lim, J.-B.; Kim, K.M.; Park, K.M.; Cho, N.H. Composite three-marker assay for early detection of kidney cancer. Cancer Epidemiol. Biomark. Prev. 2013, 22, 390-398.
54. Taylor, S.L.; Ganti, S.; Bukanov, N.O.; Chapman, A.; Fiehn, O.; Osier, M.; Kim, K.; Weiss, R.H. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am. J. Physiol. Renal Physiol. 2010, 298, F909-F922.
55. 1H nuclear magnetic resonance metabolomics analysis identifies novel urinary biomarkers for lung function. J. Proteome Res. 2010, 9, 3083-3090.
56. Michell, A.W.; Mosedale, D.; Grainger, D.J.; Barker, R.A. Metabolomic analysis of urine and serum in parkinson's disease. Metabolomics 2008, 4, 191-201.
57. Caldeira, M.; Barros, A.S.; Bilelo, M.J.; Parada, A.; Câmara, J.S.; Rocha, S.M. Profiling allergic asthma volatile metabolic patterns using a headspace-solid phase microextraction/gas chromatography based methodology. J. Chromatogr. A 2011, 1218, 3771-3780.
58. Mattarucchi, E.; Baraldi, E.; Guillou, C. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomed. Chromatogr. 2012, 26, 89-94.
59. Rocha, S.M.; Caldeira, M.; Carrola, J.; Santos, M.; Cruz, N.; Duarte, I.F. Exploring the human urine metabolomic potentialities by comprehensive two-dimensional gas chromatography coupled to time of flight mass spectrometry. J. Chromatogr. A 2012, 1252, 155-163.
60. 1H-NMR-based metabolomics study of cerebral infarction. Stroke 2011, 42, 1282-1288.
61. Bojko, B.; Cudjoe, E.; Pawliszyn, J.; Wasowicz, M. Solid-phase microextraction. How far are we from clinical practice? Trends Anal. Chem. 2011, 30, 1505-1512.
62. Vuckovic, D. High-throughput solid-phase microextraction in multi-well-plate format. Trends Anal. Chem. 2013, 45, 136-153.
63. Emerit, J.; Edeas, M.; Bricaire, F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 2004, 58, 39-46.
64. Gagliardi, A.; Miname, M.H.; Santos, R.D. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 2009, 202, 11-17.
65. Strobel, N.A.; Fassett, R.G.; Marsh, S.A.; Coombes, J.S. Oxidative stress biomarkers as predictors of cardiovascular disease. Int. J. Cardiol. 2011, 147, 191-201.
66. Ziech, D.; Franco, R.; Georgakilas, A.G.; Georgakila, S.; Malamou-Mitsi, V.; Schoneveld, O.; Pappa, A.; Panayiotidis, M.I. The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem. Biol. Interact. 2010, 188, 334-339.
67. Catapano, A.L. Antioxidant effect of flavonoids. Angiology 1997, 48, 39-44.
68. Witztum, J.L. The oxidation hypothesis of atherosclerosis. Lancet 1994, 344, 793-795.
69. Farhadi, K.; Hatami, M.; Matin, A.A. Microextraction techniques in therapeutic drug monitoring. Biomed. Chromatogr. 2012, 26, 972-989.
70. Lee, C.Y.J.; Jenner, A.M.; Halliwell, B. Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry. Biochem. Biophys. Res. Commun. 2004, 320, 696-702.
71. Prasain, J.K.; Arabshahi, A.; Taub, P.R.; Sweeney, S.; Moore, R.; Sharer, J.D.; Barnes, S. Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry. J. Chromatogr. B 2012, 913-914, 161-168.
72. Welsh, T.N.; Hubbard, S.; Mitchell, C.M.; Mesiano, S.; Zarzycki, P.K.; Zakar, T. Optimization of a solid phase extraction procedure for prostaglandin E2, F2α and their tissue metabolites. Prostag. Other Lipid Mediat. 2007, 83, 304-310.
73. Zhang, B.; Saku, K. Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS. J. Lipid Res. 2007, 48, 733-744.
74. Langhorst, M.L.; Hastings, M.J.; Yokoyama, W.H.; Hung, S.-C.; Cellar, N.; Kuppannan, K.; Young, S.A. Determination of F2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry. J. Agric. Food Chem. 2010, 58, 6614-6620.
75. Liu, W.; Morrow, J.D.; Yin, H. Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic. Biol. Med. 2009, 47, 1101-1107.
76. Magiera, S.; Baranowska, I.; Kusa, J.; Baranowski, J. A liquid chromatography and tandem mass spectrometry method for the determination of potential biomarkers of cardiovascular disease. J. Chromatogr. B 2013, 919, 20-29.
77. Magiera, S. Fast, simultaneous quantification of three novel cardiac drugs in human urine by MEPS-UHPLC-MS/MS for therapeutic drug monitoring. J. Chromatogr. B 2013, 938, 86-95.
78. Vlčková, H.; Rabatinová, M.; Mikšová, A.; Kolouchová, G.; Mičuda, S.; Solich, P.; Nováková, L. Determination of pravastatin and pravastatin lactone in rat plasma and urine using UHPLC-MS/MS and microextraction by packed sorbent. Talanta 2012, 90, 22-29.
79. Kataoka, H.; Lord, H.L.; Yamamoto, S.; Narimatsu, S.; Pawliszyn, J. Development of automated in-tube SPME/LC/MS method for drug analysis. J. Microcolumn Sep. 2000, 12, 493-500.
80. El-Beqqali, A.; Kussak, A.; Blomberg, L.; Abdel-Rehim, M. Microextraction in packed syringe/liquid chromatography/electrospray tandem mass spectrometry for quantification of acebutolol and metoprolol in human plasma and urine samples. J. Liq. Chromatogr. Relat. Technol. 2007, 30, 575-586.
81. Lin, B.; Zheng, M.M.; Ng, S.C.; Feng, Y.Q. Development of in-tube solid-phase microextraction coupled to pressure-assisted cec and its application to the analysis of propranolol enantiomers in human urine. Electrophoresis 2007, 28, 2771-2780.
82. Nielsen, K.; Lauritsen, F.R.; Nissilä, T.; Ketola, R.A. Rapid screening of drug compounds in urine using a combination of microextraction by packed sorbent and rotating micropillar array electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2012, 26, 297-303.
83. Walles, M.; Mullett, W.; Levsen, K.; Borlak, J.; Wünsch, G.; Pawliszyn, J. Verapamil drug metabolism studies by automated in-tube solid phase microextraction. J. Pharm. Biomed. Anal. 2002, 30, 307-319.
84. Daryanavard, S.M.; Jeppsson-Dadoun, A.; Andersson, L.I.; Hashemi, M.; Colmsjö, A.; Abdel-Rehim, M. Molecularly imprinted polymer in microextraction by packed sorbent for the simultaneous determination of local anesthetics: Lidocaine, ropivacaine, mepivacaine and bupivacaine in plasma and urine samples. Biomed. Chromatogr. 2013, 27, 1481-1488.
85. Guadagni, R.; Miraglia, N.; Simonelli, A.; Silvestre, A.; Lamberti, M.; Feola, D.; Acampora, A.; Sannolo, N. Solid-phase microextraction-gas chromatography-mass spectrometry method validation for the determination of endogenous substances: Urinary hexanal and heptanal as lung tumor biomarkers. Anal. Chim. Acta 2011, 701, 29-36.
86. Cavaliere, B.; Macchione, B.; Monteleone, M.; Naccarato, A.; Sindona, G.; Tagarelli, A. Sarcosine as a marker in prostate cancer progression: A rapid and simple method for its quantification in human urine by solid-phase microextraction-gas chromatography-triple quadrupole mass spectrometry. Anal. Bioanal. Chem. 2011, 400, 2903-2912.
87. Bianchi, F.; Dugheri, S.; Musci, M.; Bonacchi, A.; Salvadori, E.; Arcangeli, G.; Cupelli, V.; Lanciotti, M.; Masieri, L.; Serni, S. Fully automated solid-phase microextraction-fast gas chromatography-mass spectrometry method using a new ionic liquid column for high-throughput analysis of sarcosine and n-ethylglycine in human urine and urinary sediments. Anal. Chim. Acta 2011, 707, 197-203.
88. Monteleone, M.; Naccarato, A.; Sindona, G.; Tagarelli, A. A reliable and simple method for the assay of neuroendocrine tumor markers in human urine by solid-phase microextraction-gas chromatography-triple quadrupole mass spectrometry. Anal. Chim. Acta 2012, 759, 66-73.
89. Silva, C.; Passos, M.; Câmara, J. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. Br. J. Cancer 2011, 105, 1894-1904.
90. Mendes, B.; Silva, P.; Aveiro, F.; Pereira, J.; Câmara, J.S. A micro-extraction technique using a new digitally controlled syringe combined with uhplc for assessment of urinary biomarkers of oxidatively damaged DNA. PLoS One 2013, 8, e58366.
91. Zhang, S.-W.; Xing, J.; Cai, L.-S.; Wu, C.-Y. Molecularly imprinted monolith in-tube solid-phase microextraction coupled with HPLC/UV detection for determination of 8-hydroxy-2′-deoxyguanosine in urine. Anal. Bioanal. Chem. 2009, 395, 479-487.
92. Zhang, S.; Song, X.; Zhang, W.; Luo, N.; Cai, L. Determination of low urinary 8-hydroxy-2-deoxyguanosine excretion with capillary electrophoresis and molecularly imprinted monolith solid phase microextraction. Sci. Total Environ. 2013, 450, 266-270.
93. Bianchi, F.; Mattarozzi, M.; Careri, M.; Mangia, A.; Musci, M.; Grasselli, F.; Bussolati, S.; Basini, G. An SPME-GC-MS method using an octadecyl silica fibre for the determination of the potential angiogenesis modulators 17β-estradiol and 2-methoxyestradiol in culture media. Anal. Bioanal. Chem. 2010, 396, 2639-2645.
94. Vita, M.; Skansen, P.; Hassan, M.; Abdel-Rehim, M. Development and validation of a liquid chromatography and tandem mass spectrometry method for determination of roscovitine in plasma and urine samples utilizing on-line sample preparation. J. Chromatogr. B 2005, 817, 303-307.
95. Abdel-Rehim, M.; Skansen, P.; Vita, M.; Hassan, Z.; Blomberg, L.; Hassan, M. Microextraction in packed syringe/liquid chromatography/electrospray tandem mass spectrometry for quantification of olomoucine in human plasma samples. Anal. Chim. Acta 2005, 539, 35-39.
96. Takamoto, S.; Sakura, N.; Namera, A.; Yashiki, M. Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide. J. Chromatogr. B 2004, 806, 59-63.
97. Kuriki, A.; Kumazawa, T.; Lee, X.-P.; Hasegawa, C.; Kawamura, M.; Suzuki, O.; Sato, K. Simultaneous determination of selegiline and desmethylselegiline in human body fluids by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J. Chromatogr. B 2006, 844, 283-291.
98. Oppolzer, D.; Moreno, I.; Fonseca, B.; Passarinha, L.; Barroso, M.; Costa, S.; Queiroz, J.A.; Gallardo, E. Analytical approach to determine biogenic amines in urine using microextraction in packed syringe and liquid chromatography coupled to electrochemical detection. Biomed. Chromatogr. 2013, 27, 608-614.
99. El-Beqqali, A.; Kussak, A.; Abdel-Rehim, M. Determination of dopamine and serotonin in human urine samples utilizing microextraction online with liquid chromatography/electrospray tandem mass spectrometry. J. Sep. Sci. 2007, 30, 421-424.
100. He, J.; Liu, Z.; Ren, L.; Liu, Y.; Dou, P.; Qian, K.; Chen, H.Y. On-line coupling of in-tube boronate affinity solid phase microextraction with high performance liquid chromatography-electrospray ionization tandem mass spectrometry for the determination of cis-diol biomolecules. Talanta 2010, 82, 270-276.
101. Zhang, X.; Xu, S.; Lim, J.M.; Lee, Y.I. Molecularly imprinted solid phase microextraction fiber for trace analysis of catecholamines in urine and serum samples by capillary electrophoresis. Talanta 2012, 99, 270-276.
102. De Andrés, F.; Zougagh, M.; Castañeda, G.; Sánchez-Rojas, J.L.; Ríos, A. Screening of non-polar heterocyclic amines in urine by microextraction in packed sorbent-fluorimetric detection and confirmation by capillary liquid chromatography. Talanta 2011, 83, 1562-1567.
103. Sun, X.; Jia, Z. A brief review of biomarkers for preventing and treating cardiovascular diseases. J. Cardiovasc. Dis. Res. 2012, 3, 251-254.
104. Il'Yasova, D.; Scarbrough, P.; Spasojevic, I. Urinary biomarkers of oxidative status. Clin. Chim. Acta 2012, 413, 1446-1453.
105. Cracowski, J.-L.; Ormezzano, O. Isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases. Eur. Heart J. 2004, 25, 1675-1678.
106. Davies, S.S.; Roberts, L.J., II. F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic. Biol. Med. 2011, 50, 559-566.
107. Roest, M.; Voorbij, H.A.; van der Schouw, Y.T.; Peeters, P.H.; Teerlink, T.; Scheffer, P.G. High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women. J. Clin. Lipidol. 2008, 2, 298-303.
108. Medina, S.; Domínguez-Perles, R.; Gil, J.; Ferreres, F.; García-Viguera, C.; Martínez-Sanz, J.; Gil-Izquierdo, A. A ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hour values in healthy volunteers in a controlled constant diet. Rapid Commun. Mass Spectrom. 2012, 26, 1249-1257.
109. Il'Yasova, D.; Morrow, J.D.; Ivanova, A.; Wagenknecht, L.E. Epidemiological marker for oxidant status: Comparison of the elisa and the gas chromatography/mass spectrometry assay for urine 2, 3-dinor-5, 6-dihydro-15-F2-isoprostane. Ann. Epidemiol. 2004, 14, 793-797.
110. Mendes, B.; Silva, P.; Mendonça, I.; Pereira, J.; Câmara, J.S. A new and fast methodology to assess oxidative damage in cardiovascular diseases risk development through eVol-MEPS-UHPLC analysis of four urinary biomarkers. Talanta 2013, 116, 164-172.
111. Baranowska, I.; Magiera, S.; Baranowski, J. Clinical applications of fast liquid chromatography: A review on the analysis of cardiovascular drugs and their metabolites. J. Chromatogr. B 2013, 927, 54-79.
112. Kataoka, H.; Narimatsu, S.; Lord, H.L.; Pawliszyn, J. Automated in-tube solid-phase microextraction coupled with liquid chromatography/electrospray ionization mass spectrometry for the determination of β-blockers and metabolites in urine and serum samples. Anal. Chem. 1999, 71, 4237-4244.
113. Mullett, W.M.; Martin, P.; Pawliszyn, J. In-tube molecularly imprinted polymer solid-phase microextraction for the selective determination of propranolol. Anal. Chem. 2001, 73, 2383-2389.
114. Beger, R. A review of applications of metabolomics in cancer. Metabolites 2013, 3, 552-574.
115. Cornu, J.-N.; Cancel-Tassin, G.; Ondet, V.; Girardet, C.; Cussenot, O. Olfactory detection of prostate cancer by dogs sniffing urine: A step forward in early diagnosis. Eur. Urol. 2011, 59, 197-201.
116. Toyokuni, S. Molecular mechanisms of oxidative stress-induced carcinogenesis: From epidemiology to oxygenomics. IUBMB Life 2008, 60, 441-447.
117. Kwak, J.; Preti, G. Challenges in the Investigation of Volatile Disease Biomarkers in Urine. In Volatile Biomarkers; Amann, A., Smith, D., Eds.; Elsevier: Amsterdam, The Netherlands, 2013; pp. 394-404.
118. Peaston, R.T.; Weinkove, C. Measurement of catecholamines and their metabolites. Ann. Clin. Biochem. 2004, 41, 17-38.
119. Barocas, D.A.; Motley, S.; Cookson, M.S.; Chang, S.S.; Penson, D.F.; Dai, Q.; Milne, G.; Roberts, L.J., II; Morrow, J.; Concepcion, R.S.; et al. Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J. Urol. 2011, 185, 2102-2107.
120. Hegde, M.L.; Mantha, A.K.; Hazra, T.K.; Bhakat, K.K.; Mitra, S.; Szczesny, B. Oxidative genome damage and its repair: Implications in aging and neurodegenerative diseases. Mech. Ageing Dev. 2012, 133, 157-168.
121. Migliore, L.; Fontana, I.; Colognato, R.; Coppede, F.; Siciliano, G.; Murri, L. Searching for the role and the most suitable biomarkers of oxidative stress in alzheimer's disease and in other neurodegenerative diseases. Neurobiol. Aging 2005, 26, 587-595.
122. Bolner, A.; Pilleri, M.; de Riva, V.; Nordera, G. Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in parkinson's disease. Clin. Lab. 2011, 57, 859-866.
123. Bogdanov, M.; Matson, W.R.; Wang, L.; Matson, T.; Saunders-Pullman, R.; Bressman, S.S.; Beal, M.F. Metabolomic profiling to develop blood biomarkers for parkinson's disease. Brain 2008, 131, 389-396.
124. Bohnstedt, K.C.; Karlberg, B.; Wahlund, L.-O.; Jönhagen, M.E.; Basun, H.; Schmidt, S. Determination of isoprostanes in urine samples from alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2003, 796, 11-19.
125. Connolly, J.; Siderowf, A.; Clark, C.M.; Mu, D.; Pratico, D. F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired parkinson disease patients. Cogn. Behav. Neurol. 2008, 21, 83-86.
126. Kim, K.M.; Jung, B.H.; Paeng, K.-J.; Kim, I.; Chung, B.C. Increased urinary F2-isoprostanes levels in the patients with alzheimer's disease. Brain Res. Bull. 2004, 64, 47-51.
127. Montine, K.S.; Quinn, J.F.; Zhang, J.; Fessel, J.P.; Roberts, L.J., II; Morrow, J.D.; Montine, T.J. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem. Phys. Lipids 2004, 128, 117-124.
128. Mufson, E.J.; Leurgans, S. Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from alzheimer's disease. Neurodegener. Dis. 2010, 7, 139-142.
129. Sundelöf, J.; Kilander, L.; Helmersson, J.; Larsson, A.; Rönnemaa, E.; Degerman-Gunnarsson, M.; Sjögren, P.; Basun, H.; Lannfelt, L.; Basu, S. Systemic tocopherols and F(2)-isoprostanes and the risk of alzheimer's disease and dementia: A prospective population-based study. J. Alzheimers Dis. 2009, 18, 71-78.
130. Tuppo, E.; Forman, L.; Spur, B.; Chan-Ting, R.; Chopra, A.; Cavalieri, T. Sign of lipid peroxidation as measured in the urine of patients with probable alzheimer's disease. Brain Res. Bull. 2001, 54, 565-568.
131. Cecchi, C.; Fiorillo, C.; Sorbi, S.; Latorraca, S.; Nacmias, B.; Bagnoli, S.; Nassi, P.; Liguri, G. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial alzheimer's patients. Free Radic. Biol. Med. 2002, 33, 1372-1379.
132. Davidson, D.; Grosset, K.; Grosset, D. Parkinson's disease: The effect of L-dopa therapy on urinary free catecholamines and metabolites. Ann. Clin. Biochem. 2007, 44, 364-368.
133. Bouatra, S.; Aziat, F.; Mandal, R.; Guo, A.C.; Wilson, M.R.; Knox, C.; Bjorndahl, T.C.; Krishnamurthy, R.; Saleem, F.; Liu, P.; et al. The human urine metabolome. PLoS One 2013, 8, e73076.